Published in Eur J Immunogenet on June 01, 1992
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18
DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria. Malar J (2014) 0.81
HLA-A*33-DR3 and A*33-DR9 haplotypes enhance the risk of type 1 diabetes in Han Chinese. J Diabetes Investig (2016) 0.76
Retracted Alloreactivity and association of human natural killer cells with the major histocompatibility complex. Clin Diagn Lab Immunol (1999) 0.75
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med (1973) 2.25
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
Central MHC genes, IgA deficiency and autoimmune disease. Immunol Today (1990) 1.81
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics (1999) 1.71
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38
Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32
Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol (1971) 1.28
Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23
Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS (1992) 1.20
HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 1.20
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18
Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27. J Rheumatol Suppl (1977) 1.17
Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12
Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics (1992) 1.11
An analysis of variation in the long-range genomic organization of the human major histocompatibility complex class II region by pulsed-field gel electrophoresis. Genomics (1989) 1.11
Cancer in connective tissue disease. Arthritis Rheum (1982) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum (1981) 1.08
A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics (1994) 1.07
Family studies of IgA deficiency. Immunogenetics (1985) 1.07
Hepatocellular carcinoma: presentation with vertebral metastases and radicular compression. Cancer (1972) 1.07
The diagnostic significance of autoantibodies to the acetylcholine receptor. J Neuroimmunol (1982) 1.05
Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet (1980) 1.05
Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods (1988) 1.04
HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed) (1983) 1.04
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene (2012) 1.03
Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis. Ann N Y Acad Sci (1981) 0.99
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99
Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med (1988) 0.99
Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res (1999) 0.99
Cross-reactivity of anti-acetylcholine receptor autoantibodies. Muscle Nerve (1981) 0.98
Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27. Clin Exp Immunol (1978) 0.98
Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. Am J Med (1977) 0.98
Characterisation of immunofluorescent heterophile antibodies which may be confused with autoantibodies. J Clin Pathol (1977) 0.97
HLA class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens (2010) 0.97
Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol (1986) 0.96
Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis. J Exp Med (1990) 0.96
Positive allergy prick tests associated with bronchial histamine responsiveness in an unselected population. J Allergy Clin Immunol (1986) 0.96
Direct observation of the gene organization of the complement C4 and 21-hydroxylase loci by pulsed field gel electrophoresis. J Exp Med (1989) 0.95
Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust (1992) 0.95
The implications of intergenic polymorphism for major histocompatibility complex evolution. Genetics (2000) 0.95
MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome. Hum Immunol (2006) 0.95
Coevolution of PERB11 (MIC) and HLA class I genes with HERV-16 and retroelements by extended genomic duplication. J Mol Evol (1999) 0.95
Corneodesmosin gene: no evidence for PSORS 1 gene in North-eastern Thai psoriasis patients. Tissue Antigens (2003) 0.94
HLA in systemic lupus erythematosus: influence on severity. Tissue Antigens (1978) 0.94
Cytotoxic effect of antisera on 51Cr-labelled monolayers of skeletal muscle. J Pathol (1973) 0.93
Angioimmunoblastic lymphadenopathy with dysproteinemia. Cancer (1977) 0.93
The major histocompatability complex (MHC) contains conserved polymorphic genomic sequences that are shuffled by recombination to form ethnic-specific haplotypes. J Mol Evol (1997) 0.93
Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol (1991) 0.92
Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles. Immunogenetics (1985) 0.92
Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis. Br Med J (1975) 0.92
Myogenesis in vitro as demonstrated by immunofluorescent staining with antimuscle serum. Exp Cell Res (1971) 0.92
Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. Report of a case with unusual mitochondrial changes and lipid accumulation in muscle. J Neurol Sci (1977) 0.91
Immunological assessment of mice with chronic jaundice and runting induced by reovirus 3. Br J Exp Pathol (1973) 0.90
Antinuclear antibody. Precise and accurate quantitation without serial dilution. J Immunol Methods (1986) 0.90
Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais. Tissue Antigens (2001) 0.90
C4 allotyping on plasma or serum: application to routine laboratories. Hum Immunol (1988) 0.90
Immunoglobulin deposition in liver of patients with active chronic hepatitis and antibody against smooth muscle. Br Med J (1973) 0.90
Haplotypic polymorphisms of the TNFB gene. Immunogenetics (1991) 0.90
Genomic organization of a polymorphic duplicated region centromeric of HLA-B. Immunogenetics (1992) 0.89
Comparison between two human endogenous retrovirus (HERV)-rich regions within the major histocompatibility complex. J Mol Evol (1999) 0.88
The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis. Clin Exp Immunol (1977) 0.88
Allelic and interlocus comparison of the PERB11 multigene family in the MHC. Immunogenetics (1997) 0.88
Polymyositis and myasthenia gravis: immunodeficiency disorders involving skeletal muscle. Lancet (1975) 0.88
The evolution of MHC diversity by segmental duplication and transposition of retroelements. J Mol Evol (1997) 0.88
Joint report of the Third International Bovine Lymphocyte Antigen (BoLA) Workshop, Helsinki, Finland, 27 July 1986. Anim Genet (1989) 0.88
Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis. Scand J Rheumatol Suppl (1979) 0.88
Monozygotic twins from in vitro fertilization. Fertil Steril (1984) 0.87
Analysis of MHC genomic structure and gene content between HLA-B and TNF using yeast artificial chromosomes. Genomics (1993) 0.87
Comparative mapping of the human major histocompatibility complex in different racial groups by pulsed field gel electrophoresis. Hum Immunol (1989) 0.87
Western blot profiles, lymph node ultrastructure and viral expression in HIV-infected patients: a correlative study. Clin Exp Immunol (1987) 0.87
Sequencing of 42kb of the APO E-C2 gene cluster reveals a new gene: PEREC1. DNA Seq (1998) 0.87
Histamine sensitivity influences reactivity to allergens. J Allergy Clin Immunol (1985) 0.87
New major histocompatibility complex genes. Hum Immunol (1993) 0.87
Surface antigens of differentiated muscle cells in monolayer demonstrated by immunofluorescence and cytotoxicity. J Immunol Methods (1972) 0.87
Familial occurrence of alpha 1-antitrypsin deficiency and Weber-Christian disease. Arch Dermatol (1983) 0.86
Prevalence of ankylosing spondylitis and radiological abnormalities of the sacroiliac joints in HLA-B27 positive individuals. J Rheumatol (1982) 0.86
Myasthenia gravis and HLA antigens in American blacks and other races. J Neuroimmunol (1984) 0.86
HLA and complement genetic markers in diabetic retinopathy. Diabetologia (1983) 0.86
Penicillamine treatment of rheumatoid arthritis: relationship of proteinuria and autoantibodies to immune status. Proc R Soc Med (1977) 0.86
A classification of anti-heart antibodies: differentiation between heart-specific and heterophile antibodies. Clin Immunol Immunopathol (1977) 0.85
Population study of heterophile antibodies. Vox Sang (1980) 0.85
The prevalence of ankylosing spondylitis among B27 positive normal individuals--a reassessment. J Rheumatol (1980) 0.85
Distributions of HLA-DRB1/DQB1 alleles and haplotypes in the north-eastern Thai population: indicative of a distinct Thai population with Chinese admixtures in the central Thais. Eur J Immunogenet (1999) 0.85
SEAPAL quality control analysis of rheumatoid factor measurement in 29 diagnostic laboratories. Ann Rheum Dis (1987) 0.84